Volume 70, Issue 4 , Pages 1229-1238, 15 March 2008
Comparison of Different Strategies to Use Four-Dimensional Computed Tomography in Treatment Planning for Lung Cancer Patients
Purpose
To discuss planning target volumes (PTVs) based on internal target volume (PTVITV), exhale-gated radiotherapy (PTVGating), and a new proposed midposition (PTVMidP; time-weighted mean tumor position) and compare them with the conventional free-breathing CT scan PTV (PTVConv).
Methods and Materials
Respiratory motion induces systematic and random geometric uncertainties. Their contribution to the clinical target volume (CTV)-to-PTV margins differs for each PTV approach. The uncertainty margins were calculated using a dose–probability-based margin recipe (based on patient statistics). Tumor motion in four-dimensional CT scans was determined using a local rigid registration of the tumor. Geometric uncertainties for interfractional setup errors and tumor baseline variation were included. For PTVGating, the residual motion within a 30% gating (time) window was determined. The concepts were evaluated in terms of required CTV-to-PTV margin and PTV volume for 45 patients.
Results
Over the patient group, the PTVITV was on average larger (+6%) and the PTVGating and PTVMidP smaller (−10%) than the PTVConv using an off-line (bony anatomy) setup correction protocol. With an on-line (soft tissue) protocol the differences in PTV compared with PTVConv were +33%, −4%, and 0, respectively.
Conclusions
The internal target volume method resulted in a significantly larger PTV than conventional CT scanning. The exhale-gated and mid-position approaches were comparable in terms of PTV. However, mid-position (or mid-ventilation) is easier to use in the clinic because it only affects the planning part of treatment and not the delivery.
Computed tomography, Lung cancer, Geometric uncertainties, Planning target volume margin
To access this article, please choose from the options below
Supported by a grant from the Dutch Cancer Society (NKI 03-2943).
Presented in part at the 2006 (Leipzig, Germany) and 2007 (Barcelona, Spain) Annual Meetings of the European Society for Therapeutic Radiology and Oncology (ESTRO).
Conflict of interest: J.-J. Sonke is partly sponsored by Elekta Oncology Systems.
PII: S0360-3016(07)04592-0
doi:10.1016/j.ijrobp.2007.11.042
© 2008 Elsevier Inc. All rights reserved.
Volume 70, Issue 4 , Pages 1229-1238, 15 March 2008
